Contact
searchSearch
HMP Global

News

sunscreen
News
FDA Approves Bemotrizinol: What Dermatologists Need to Know
06/11/2026
Jane Y. Yoo, MD; Riya Gandhi, MA
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol. Dr Yoo discusses how this photostable, broad-spectrum UV filter may improve UVA protection, expand cosmetically elegant sunscreen options for diverse...
The Dermatologist spoke with Dr...
06/11/2026
The Dermatologist
News
Nail Abnormalities Common in Severe Atopic Dermatitis, Study Finds
06/09/2026
Jessica Garlewicz
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly...
06/09/2026
The Dermatologist
News
Emergency Department Management of Pediatric Atopic Dermatitis Requires Accurate Triage and Structured Discharge Planning
06/09/2026
Jessica Garlewicz
Atopic dermatitis, the most common inflammatory skin disease of childhood, affects up to 20% of children in the United States and remains a frequent reason for emergency department visits.
Atopic dermatitis, the most common inflammatory skin disease of childhood, affects up to 20% of children in the United States and remains a frequent reason for emergency department visits.
Atopic dermatitis, the most...
06/09/2026
The Dermatologist
News
Age-Specific Immune Signatures Identified Across the Atopic Dermatitis Lifespan
06/09/2026
Jessica Garlewicz
Using Cellular Indexing of Transcriptomes and Epitopes by sequencing, investigators simultaneously assessed transcriptomic and surface proteomic profiles across approximately 280,000 immune cells.
Using Cellular Indexing of Transcriptomes and Epitopes by sequencing, investigators simultaneously assessed transcriptomic and surface proteomic profiles across approximately 280,000 immune cells.
Using Cellular Indexing of...
06/09/2026
The Dermatologist
News
Psoriasis Not Genetically Linked to Renal Impairment, Mendelian Randomization Study Finds
06/04/2026
Jessica Garlewicz
A Mendelian randomization study found no evidence that genetic susceptibility to psoriasis causally contributes to renal impairment, challenging prior observational reports that have linked psoriasis to kidney dysfunction.
A Mendelian randomization study found no evidence that genetic susceptibility to psoriasis causally contributes to renal impairment, challenging prior observational reports that have linked psoriasis to kidney dysfunction.
A Mendelian randomization study...
06/04/2026
The Dermatologist
News
Biologic Therapy Not Linked to Overall Reduction in Psoriatic Arthritis Risk
06/04/2026
Jessica Garlewicz
Biologic therapy was not associated with a significantly reduced overall risk of incident psoriatic arthritis among patients with psoriasis, although subgroup findings suggested potential differences by data source and biologic class.
Biologic therapy was not associated with a significantly reduced overall risk of incident psoriatic arthritis among patients with psoriasis, although subgroup findings suggested potential differences by data source and biologic class.
Biologic therapy was not...
06/04/2026
The Dermatologist
News
Psoriasis May Be Associated With Greater Treatment Burden in Patients With Inflammatory Bowel Disease
06/04/2026
Jessica Garlewicz
Patients with inflammatory bowel disease (IBD) and preexisting psoriasis may require more intensive treatment and experience a more aggressive disease course than patients with IBD alone.
Patients with inflammatory bowel disease (IBD) and preexisting psoriasis may require more intensive treatment and experience a more aggressive disease course than patients with IBD alone.
Patients with inflammatory bowel...
06/04/2026
The Dermatologist
News
Psoriasis May Be Linked to Accelerated Cellular Senescence Through Inflammaging Pathways
06/04/2026
Jessica Garlewicz
The review highlights the role of chronic immune activation in driving persistent inflammation.
The review highlights the role of chronic immune activation in driving persistent inflammation.
The review highlights the role...
06/04/2026
The Dermatologist
News
Spesolimab Shows Potential in Treating GPP With Palmoplantar Pustulosis
05/20/2026
Jessica Garlewicz
Spesolimab, an interleukin-36 receptor antagonist, may offer an effective treatment option for patients with generalized pustular psoriasis complicated by palmoplantar pustulosis.
Spesolimab, an interleukin-36 receptor antagonist, may offer an effective treatment option for patients with generalized pustular psoriasis complicated by palmoplantar pustulosis.
Spesolimab, an interleukin-36...
05/20/2026
The Dermatologist
News
Oral Icotrokinra Demonstrates High Efficacy and Favorable Safety in Plaque Psoriasis
05/12/2026
Jessica Garlewicz
Investigators analyzed 5 randomized trials including 1951 patients receiving icotrokinra 200 mg once daily or placebo.
Investigators analyzed 5 randomized trials including 1951 patients receiving icotrokinra 200 mg once daily or placebo.
Investigators analyzed 5...
05/12/2026
The Dermatologist

Popular Articles

AD
News
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis
06/13/2024
Riya Gandhi, MA
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on...
06/13/2024
The Dermatologist
Clinical Insights
The Risk of Keratinocyte Cancer in Patients With Vitiligo
08/05/2024
Riya Gandhi, MA
A recent systematic review and meta-analysis offers insights into the relationship between vitiligo and nonmelanoma skin cancer, which can be used to enhance patient education.
A recent systematic review and meta-analysis offers insights into the relationship between vitiligo and nonmelanoma skin cancer, which can be used to enhance patient education.
A recent systematic review and...
08/05/2024
The Dermatologist
atopic dermatitis
FDA Alerts
Lebrikizumab FDA Approved for Moderate to Severe Atopic Dermatitis in Adults and Children
09/16/2024
Jessica Garlewicz
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug...
09/16/2024
The Dermatologist
eczema
News
Novel Efficacy Index Compares Long-Term Therapy Outcomes in Atopic Dermatitis Treatments
06/22/2024
Riya Gandhi, MA
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess...
06/22/2024
The Dermatologist
acne
News
Evidence-Based Recommendations for Acne Management
08/09/2024
Jessica Garlewicz
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a...
08/09/2024
The Dermatologist
June 2026 issue

Current Issue

June 2026
Volume 34
Issue 4
Current Issue
Issue Archive

Latest Quizzes and Trivia

brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use